Diabetes worsens ischemia-reperfusion brain injury in rats through GSK-3β

American Journal of the Medical Sciences

Volumn 350, Issue 3, 2015, Pages 204-211

  Liu, Hua ^a   Ou, Shanshan ^a   Xiao, Xiaoyu ^a   Zhu, Yingxian ^a   Zhou, Shaopeng ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Cerebral injury; Diabetes mellitus; Glycogen synthase kinase 3 (GSK 3 ); Ischemia reperfusion; Nuclear factor B (NF B); Tumor necrosis factor (TNF )

Indexed keywords

CASPASE 3; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; 4-BENZYL-2-METHYL-1,2,4-THIADIAZOLIDINE-3,5-DIONE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; THIADIAZOLE DERIVATIVE;

ABDOMINAL DISTENSION; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY WEIGHT; BRADYKINESIA; BRAIN INJURY; BRAIN TISSUE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; DISEASE EXACERBATION; DYSTHYMIA; EMACIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HIPPOCAMPAL CA1 REGION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SHAM PROCEDURE; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TUNEL ASSAY; URINE ODOR; URINE VOLUME; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN CORTEX; BRAIN ISCHEMIA; COMPLICATION; DIABETIC ANGIOPATHY; DRUG EFFECTS; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; HIPPOCAMPUS; LIMB; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; APOPTOSIS; BRAIN ISCHEMIA; CEREBRAL CORTEX; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; EXTREMITIES; GLYCOGEN SYNTHASE KINASE 3; HIPPOCAMPUS; MALE; NF-KAPPA B; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; THIADIAZOLES;

EID: 84941111712     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1097/MAJ.0000000000000540     Document Type: Article

References (44)

1. Sims-Robinson C, Kim B, Rosko A, et al. How does diabetes accelerate Alzheimer disease pathology?. Nat Rev Neurol. 2010; 6: 551-9.
2. Gold SM, Dziobek I, Sweat V, et al. Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes. Diabetologia. 2007; 50: 711-9.
3. Cox DJ, Kovatchev BP, Gonder-Frederick LA, et al. Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes. Diabetes Care. 2005; 28: 71-7.
4. Wrighten SA, Piroli GG, Grillo CA, et al. A look inside the diabetic brain: contributors to diabetes-induced brain aging. Biochim Biophys Acta. 2009; 1792: 444-53.
5. Biessels GJ, van der Heide LP, Kamal A, et al. Ageing and diabetes: implications for brain function. Eur J Pharmacol. 2002; 441: 1-14.
6. Li PA, He QP, Yi-Bing O, et al. Phosphorylation of extracellular signal-regulated kinase after transient cerebral ischemia in hyperglycemic rats. Neurobiol Dis. 2001; 8: 127-35.
7. Yassin MM, Harkin DW, Barros DSa AA, et al. Lower limb ischemia-reperfusion injury triggers a systemic inflammatory response and multiple organ dysfunction. World J Surg. 2002; 26: 115-21.
8. Bianco-Batlles MD, Sosunov A, Polin RA, et al. Systemic inflammation following hind-limb ischemia-reperfusion affects brain in neonatal mice. Dev Neurosci. 2008; 30: 367-73.
9. Takahashi-Yanaga F. Activator or inhibitor?. GSK-3 as a new drug target. Biochem Pharmacol. 2013; 86: 191-9.
10. Miyashita K, Nakada M, Shakoori A, et al. An emerging strategy for cancer treatment targeting aberrant glycogen synthase kinase 3 beta. Anticancer Agents Med Chem. 2009; 9: 1114-22.
11. Cole AR, Astell A, Green C, et al. Molecular connexions between dementia and diabetes. Neurosci Biobehav Rev. 2007; 31: 1046-63.
12. Qu Z, Jiao Z, Sun X, et al. Effects of streptozotocin-induced diabetes on tau phosphorylation in the rat brain. Brain Res. 2011; 1383: 300-6.
13. Jolivalt CG, Lee CA, Beiswenger KK, et al. Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimers disease and correction by insulin. J Neurosci Res. 2008; 86: 3265-74.
14. King MR, Anderson NJ, Guernsey LS, et al. Glycogen synthase kinase-3 inhibition prevents learning deficits in diabetic mice. J Neurosci Res. 2013; 91: 506-14.
15. Beurel E, Michalek SM, Jope RS. Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3). Trends Immunol. 2010; 31: 24-31.
16. Zhang X, Zhang X, Wang C, et al. Neuroprotection of early and shorttime applying berberine in the acute phase of cerebral ischemia: upregulated pAkt, pGSK and pCREB, down-regulated NF-kappaB expression, ameliorated BBB permeability. Brain Res. 2012; 1459: 61-70.
17. Wang MJ, Huang HY, Chen WF, et al. Glycogen synthase kinase-3beta inactivation inhibits tumor necrosis factor-Alpha production in microglia by modulating nuclear factor kappaB and MLK3/JNK signaling cascades. J Neuroinflammation. 2010; 7: 99.
18. Dugo L, Collin M, Thiemermann C. Glycogen synthase kinase 3beta as a target for the therapy of shock and inflammation. Shock. 2007; 27: 113-23.
19. Kim B, Sullivan KA, Backus C, et al. Cortical neurons develop insulin resistance and blunted Akt signaling: a potential mechanism contributing to enhanced ischemic injury in diabetes. Antioxid Redox Signal. 2011; 14: 1829-39.
20. Collino M, Aragno M, Castiglia S, et al. Insulin reduces cerebral ischemia/reperfusion injury in the hippocampus of diabetic rats: a role for glycogen synthase kinase-3beta. Diabetes. 2009; 58: 235-42.
21. Albadawi H, Oklu R, Cormier NR, et al. Hind limb ischemiareperfusion injury in diet-induced obese mice. J Surg Res. 2014; 190(2): 683-91.
22. Szijarto A, Turoczi Z, Szabo J, et al. Rapidly progressing fatal reperfusion syndrome caused by acute critical ischemia of the lower limb. Cardiovasc Pathol. 2013; 22: 493-500.
23. Ordy JM, Wengenack TM, Bialobok P, et al. Selective vulnerability and early progression of hippocampal CA1 pyramidal cell degeneration and GFAP-positive astrocyte reactivity in the rat four-vessel occlusion model of transient global ischemia. Exp Neurol. 1993; 119: 128-39.
24. Draznin B, Miles P, Kruszynska Y, et al. Effects of insulin on prenylation as a mechanism of potentially detrimental influence of hyperinsulinemia. Endocrinology. 2000; 141: 1310-6.
25. Yang Y, Ma D, Wang Y, et al. Intranasal insulin ameliorates tau hyperphosphorylation in a rat model of type 2 diabetes. J Alzheimers Dis. 2013; 33: 329-38.
26. Zhang T, Pan BS, Sun GC, et al. Diabetes synergistically exacerbates poststroke dementia and tau abnormality in brain. Neurochem Int. 2010; 56: 955-61.
27. Hayden MS, Ghosh S. NF-kappaB in immunobiology. Cell Res. 2011; 21: 223-44.
28. Yenari MA, Han HS. Influence of hypothermia on post-ischemic inflammation: role of nuclear factor kappa B (NFkappaB). Neurochem Int. 2006; 49: 164-9.
29. Lin M, Li L, Li L, et al. The protective effect of baicalin against renal ischemia-reperfusion injury through inhibition of inflammation and apoptosis. BMC Complement Altern Med. 2014; 14: 19.
30. Sun BZ, Chen L, Wu Q, et al. Suppression of inflammatory response by flurbiprofen following focal cerebral ischemia involves the NF-kB signaling pathway. Int J Clin Exp Med. 2014; 7: 3087-95.
31. Ahmed MA, El Morsy EM, Ahmed AA. Pomegranate extract protects against cerebral ischemia/reperfusion injury and preserves brain DNA integrity in rats. Life Sci. 2014; 110: 61-9.
32. Seegers H, Grillon E, Trioullier Y, et al. Nuclear factor-kappa B activation in permanent intraluminal focal cerebral ischemia in the rat. Neurosci Lett. 2000; 288: 241-5.
33. Wang Y, Kawamura N, Schmelzer JD, et al. Decreased peripheral nerve damage after ischemia-reperfusion injury in mice lacking TNFalpha. J Neurol Sci. 2008; 267: 107-11.
34. Huck V, Niemeyer A, Goerge T, et al. Delay of acute intracellular pH recovery after acidosis decreases endothelial cell activation. J Cell Physiol. 2007; 211: 399-409.
35. Durukan A, Tatlisumak T. Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav. 2007; 87: 179-97.
36. Banks WA. The blood-brain barrier in psychoneuroimmunology. Immunol Allergy Clin North Am. 2009; 29: 223-8.
37. Banks WA, Farr SA, La Scola ME, et al. Intravenous human interleukin-1alpha impairs memory processing in mice: dependence on blood-brain barrier transport into posterior division of the septum. J Pharmacol Exp Ther. 2001; 299: 536-41.
38. Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci. 2007; 8: 57-69.
39. Ransohoff RM, Engelhardt B. The anatomical and cellular basis of immune surveillance in the central nervous system. Nat Rev Immunol. 2012; 12: 623-35.
40. Pifarre P, Prado J, Giralt M, et al. Cyclic GMP phosphodiesterase inhibition alters the glial inflammatory response, reduces oxidative stress and cell death and increases angiogenesis following focal brain injury. J Neurochem. 2010; 112: 807-17.
41. Bonheur JA, Albadawi H, Patton GM, et al. A noninvasive murine model of hind limb ischemia-reperfusion injury. J Surg Res. 2004; 116: 55-63.
42. Wilson JS, Rushing G, Johnson BL, et al. The effects of dichloroacetate in a rabbit model of acute hind-limb ischemia and reperfusion. J Am Coll Surg. 2003; 197: 591-5.
43. Crawford RS, Hashmi FF, Jones JE, et al. A novel model of acute murine hindlimb ischemia. Am J Physiol Heart Circ Physiol. 2007; 292: H830-7.
44. Islam MS, Loots du T. Experimental rodent models of type 2 diabetes: a review. Methods Find Exp Clin Pharmacol. 2009; 31: 249-61.